Ergomed PLC's (LON:ERGO) Richard Barfield presents the latest trading statement to investors, which reveal 2020 will be ahead of expectations.
Barfield says 2020 has been 'another good year, with strong top line growth and overall financial performance'.
The company said it expects revenue for 2020 will be around £86.4mln, up 26.5% on 2019’s £68.3mln.
Price: 1190 GBX
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Ergomed PLC named herein, including the promotion by the Company of Ergomed PLC in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HERE
Ergomed PLC's (LON:ERGO) Executive Chairman, Dr Miroslav Reljanović talks to Proactive London's Katie Pilbeam about their 'very exciting and highly attractive' acquisition of MedSource in a deal worth up to US$25mln. MedSource is a US-based specialist oncology and rare disease contract...
Prev article
